LOS ANGELES, CA / ACCESSWIRE / May 26, 2017 / BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today announced that it will be presenting at the 7th annual LD Micro Invitational on Wednesday, June 7 at 8:30 AM PST / 11:30 AM EST. Jonathan Adams, CEO, will be giving the presentation and will be meeting with investors.

Conference participants who are interested in scheduling a meeting are encouraged to sign up through the conference’s portal, or by calling Tony Schor at 847-945-2222 ext. 221.

BioVie is currently focused on developing and commercializing BIV201, its lead therapeutic candidate and novel approach to the treatment of refractory ascites due to advanced liver cirrhosis. BioVie will soon commence a Phase 2a clinical trial in six of these patients. BIV201 is a continuous ambulatory infusion of the peptide terlipressin and has Orphan drug status and patent protection in the US. Terlipressin, dosed differently, is approved in about 40 countries for other complications of liver cirrhosis arising from a similar disease pathway. Terlipressin is not available in the US and currently there are no FDA-approved drugs specifically for treating ascites which represents a significant unmet medical need.

BIV201 could become the first drug ever approved by the FDA for treating refractory ascites due to liver cirrhosis, a life-threatening condition which affects about 10,000 Americans. The condition results primarily from hepatitis, alcoholism, and nonalcoholic steatohepatitis (NASH) linked to fatty liver disease and obesity. Ascites is a common complication of advanced liver cirrhosis and an estimated 40% of patients die within two years of diagnosis. Certain drugs approved for other uses may provide initial relief, but patients often fail to respond to them as ascites worsens. US treatment costs for liver cirrhosis, including ascites and other complications, are estimated at more than $4 billion annually.

“This year, not only do we have a record number of companies making their LD Micro debuts, but a record number of companies presenting for the first time in their company’s history” stated Chris Lahiji, President of LD Micro. “LD has established itself as the one venue that brings the most influential players from all segments of the market under one roof.”

The conference will be held at the Luxe Sunset Bel Air Hotel and will feature 180 companies in the small / micro-cap space.

View BioVie Inc. profile here: https://www.ldmicro.com/profile/BIVI

Profiles powered by LD Micro – News Compliments of Accesswire.

About BioVie, Inc.

BioVie Inc. is a clinical-stage company pursuing the discovery, development, and commercialization of innovative drug therapies. The Company is currently focused on developing and commercializing BIV201, a novel approach to the treatment of ascites due to chronic liver cirrhosis. In March 2017, BioVie received notification from the FDA that it could initiate a Phase 2a US clinical trial. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. It has Orphan Drug designation for the most common of these complications, ascites, which represents a significant unmet medical need. The FDA has never approved any drug specifically for treating ascites. For more information about BioVie and BIV201, please visit our website: www.biovieinc.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

BioVie Contact:
Tony Schor
Investor Awareness, Inc.
847.945.2222 ext. 221
tony@investorawarenes.com

SOURCE: BioVie Inc.

ReleaseID: 464267

LOS ANGELES, CA / ACCESSWIRE / May 26, 2017 / MariMed Inc. (OTCQB: MRMD), will be presenting at the 7th annual LD Micro Invitational on Tuesday, June 6, at 1:30 PM PST / 4:30 PM EST. Mr. Jon Levine, CFO of MariMed Advisors, will be highlighting MariMed’s recent achievements, its precision dosed products, and cannabis business services that have shaped some of the nation’s foremost medical cannabis cultivation, production and dispensary facilities. To arrange a meeting with management, please contact Robert Haag at mrmd@irthcommunications.com or 1-866-976-4784.

“This year, not only do we have a record number of companies making their LD Micro debuts, such as MariMed, but a record number of companies presenting for the first time in their company’s history,” stated Mr. Chris Lahiji, President of LD Micro. “LD has established itself as the one venue that brings the most influential players from all segments of the market under one roof.”

The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, Calif., and will feature 180 companies in the small/micro-cap space.

View MariMed’s profile here: https://www.ldmicro.com/profile/MRMD

Profiles powered by LD Micro – News Compliments of Accesswire.

About MariMed (formerly Worlds Online):

MariMed Inc., is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation,production, and dispensary facilities. MariMed’s team has developed five state-of-the-art, regulatory-compliant facilities in three states, with six additional facilities currently under development in two other states. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed products for the treatment of specific medical conditions. MariMed branded products are being distributed in three states with distribution being finalized in six additional states. For additional information about MariMed, visit www.MarimedAdvisors.com

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact Mr. David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

MariMed Business Development
Jon Levine, CFO, MariMed Advisors
844-244-0200

Investor Relations
+1-866-976-4784

Media Relations
Julie Shepherd, Accentuate PR
847-275-3643

SOURCE: MariMed Inc.

ReleaseID: 464245

Upcoming AWS Coverage on Spectrum Brands Holdings Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. announces its post-earnings coverage on Coty Inc. (NYSE: COTY). The Company posted its third quarter fiscal 2017 financial results on May 10, 2017. The beauty products Company surpassed top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Coty’s competitors within the Personal Products space, Spectrum Brands Holdings, Inc. (NYSE: SPB), reported results for Q2 FY17 ended April 02, 2017. AWS will be initiating a research report on Spectrum Brands Holdings in the coming days.

Today, AWS is promoting its earnings coverage on COTY; touching on SPB. Get our free coverage by signing up to:
http://www.activewallst.com/register/.

Earnings Reviewed

Coty has done multiple transactions in the past one year in the beauty business. The Company acquired more than 40 brands from Procter & Gamble Co., the personal care and beauty business of Brazil’s Hypermarcas SA; a majority stake in online cosmetics retailer Younique; as well as premium hairstyling appliances Company ghd (good hair day). The Company’s reported results reflected the performance of the business adding in the performance of the acquired brands.

For the three months ended March 31, 2017, Coty’s net revenues of $2.03 billion more than doubled compared to Legacy-Coty’s net revenues of $950.7 million in Q3 FY16 and increased 6% at constant currency compared to combined Legacy-Coty and P&G Beauty Businesses’ net revenues in the prior year’s same period. The Company’s revenue numbers exceeded analysts’ consensus of $1.96 billion.

For Q3 FY17, Coty’s gross margin was 59.8% a decrease from gross margin of 61.2% for Legacy-Coty in Q3 FY16, while adjusted gross margin was 63.3% an increase from adjusted gross margin of 61.8% for Legacy-Coty in the prior year’s same period, reflecting the addition of the higher gross margin P&G Beauty and Younique businesses.

For Q3 FY17, Coty reported operating loss of $(192.5) million compared to operating income of $23.0 million for Legacy-Coty in Q3 FY16, as the income contribution from the acquired businesses was more than offset by increased restructuring costs and acquisition related costs. As a percentage of net revenues, operating margin was a negative (9.5)% versus 2.4% in the prior year’s comparable quarter. Coty’s adjusted operating income increased >100% to $208.3 million compared to $102.6 million for Legacy-Coty in the prior year’s same period, while as a percentage of net revenues, adjusted operating margin remained flat at 10.3%.

For Q3 FY17, Coty’s net loss was $(164.2) million, or $(0.22) per diluted share, compared to net loss of $(26.8) million, or $(0.08) per diluted share, for Legacy-Coty in the prior year’s same period. The Company’s adjusted net income increased to $110.3 million in the reported quarter, from $47.8 million for Legacy-Coty in the prior year’s comparable period, primarily reflecting higher adjusted operating income and partially offset by higher interest expense. On a per-share basis, adjusted earnings totaled $0.15 per share, beating Wall Street’s expectations of $0.11 per share.

Segment Results

During Q3 FY17, Coty’s Luxury net revenues were $634.6 million, increasing 56% as reported compared to Legacy-Coty net revenues of $405.9 million in Q3 FY16, reflecting the contribution from the acquired P&G Beauty Business. The Company’s adjusted operating income from the Luxury business increased 94% to $86.1 million from $44.4 million in the prior year’s same period, resulting in adjusted operating income margin of 13.6%, an increase of 270 basis points versus the year ago comparable period.

Coty’s Consumer Beauty net revenues of $988.6 million increased >100% in Q3 FY17 compared to Legacy-Coty’s net revenues of $488.5 million in Q3 FY16, reflecting the contribution from the acquired P&G Beauty Business and Younique. During the reported quarter, adjusted operating income for Consumer Beauty increased >100% to $121.5 million from $43.2 million for Legacy-Coty in the prior year’s same period, resulting in an 12.3% adjusted operating income margin, an increase of 350 basis points on a y-o-y basis.

For Q3 FY17, Coty’s Professional Beauty segment’s net revenues was $408.9 million, surging more than six times compared to Legacy-Coty’s net revenues of $56.3 million in Q3 FY16, reflecting the contribution from the acquired P&G Beauty Business and the ghd acquisition. Adjusted operating income for Professional segment decreased to $0.7 million from $15.0 million for Legacy-Coty in the prior year’s same period, resulting in adjusted operating income margin of 0.2% versus 26.6% for Legacy-Coty in the year earlier corresponding quarter.

Cash Flows

During Q3 FY17, Coty’s net cash generated by operating activities was $43.3 million compared to cash utilization of $(71.8) million for Legacy-Coty in the prior year’s same period, reflecting improved working capital for the combined Company. Coty’s free cash flow was $(82.5) million in the reported quarter compared to $(108.6) million for Legacy-Coty in the prior year’s comparable period, reflecting higher cash from operations which was partially offset by increased capital expenditure.

Coty’s cash and cash equivalents were $767.0 million, increasing by $394.6 million; total debt was $7.18 billion, increasing by $3.01 billion, with net debt of $6.42 billion up $2.62 billion from the balance on June 30, 2016. This increase reflected the assumption of approximately $1.94 billion of debt as part of the P&G Beauty Business transaction and financings for the acquisition of ghd and the investment in Younique.

In a separate press release on May 10, 2017, Coty’s Board of Directors declared a quarterly cash dividend of $0.125 per common share, payable on June 13, 2017, to shareholders of record on May 31, 2017.

Stock Performance

At the closing bell, on Thursday, May 25, 2017, Coty’s stock slightly fell 0.90%, ending the trading session at $18.73. A total volume of 3.80 million shares were traded at the end of the day. In the last month and previous three months, shares of the Company have advanced 3.37% and 0.38%, respectively. Moreover, the stock gained 2.29% since the start of the year. The stock currently has a market cap of $13.91 billion and has a dividend yield of 2.67%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464309

Upcoming AWS Coverage on Masimo Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. announces its post-earnings coverage on Hologic, Inc. (NASDAQ: HOLX). The Company announced its financial results for the second quarter fiscal 2017 (Q2 FY17) on May 10, 2017. The Marlborough, Massachusetts-based Company’s total revenues and non-GAAP diluted EPS grew 3.2% and 6.4% y-o-y, respectively; outperforming market consensus estimates. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Hologic’s competitors within the Medical Appliances & Equipment space, Masimo Corp. (NASDAQ: MASI), reported on May 03, 2017, its financial results for the first quarter ended April 01, 2017. AWS will be initiating a research report on Masimo in the coming days.

Today, AWS is promoting its earnings coverage on HOLX; touching on MASI. Get our free coverage by signing up to:
http://www.activewallst.com/register/.

Earnings Reviewed

For the three months ended on April 01, 2017, Hologic’ total revenues were $715.4 million, up from $693.3 million reported in the prior year’s corresponding quarter. Total revenues for the reported quarter topped analysts’ forecasts of $685.4 million. On a constant currency basis, the Company’s total revenues grew 3.8% y-o-y. Furthermore, base business’ (excluding the effects of sale of blood screening and the acquired Cynosure business) revenue increased 4.7%, or 5.4% y-o-y in constant currency terms, in Q2 FY17.

Hologic’s GAAP net income surged during Q2 FY17 to $526.8 million, or $1.84 per diluted share, from $68.9 million, or $0.24 per diluted share, in Q2 FY16. The Company’s non-GAAP net income for Q2 FY17 stood at $142.7 million, or $0.50 per diluted share, compared to $135.7 million, or $0.47 per diluted share, in Q2 FY16. Wall Street had expected the Company to report non-GAAP net income of $0.46 per diluted share.

Operating Metrics

In Q2 FY17, Hologic’s GAAP gross profit came in at $388.7 million, or 54.3% of total revenues, versus $385.0 million, or 55.5% of total revenues, in Q2 FY16. Furthermore, non-GAAP gross profit for the reported quarter came in at $457.1 million, or 63.9% of total revenues, compared to $456.3 million, or 65.8% of total revenues in the prior year’s same quarter.

Hologic’s GAAP income from operations surged to $999.8 million, or 139.8% of total revenues, in Q2 FY17 from $136.1 million, or 19.6% of total revenues, in Q2 FY16. During the reported quarter, the Company has reported one-time gain of $899.7 million on sale of its blood screening business. Moreover, the Company’s Q2 FY17 non-GAAP income from operations came in at $234.1 million, or 32.7% of total revenues, compared to $235.1 million, or 33.9% of total revenues, in Q2 FY16. The Company’s adjusted EBITDA for Q2 FY17 stood at $255.9 million, rising 0.8% from $253.8 million in Q2 FY16.

Segment Revenues

During Q2 FY17, total Diagnostics revenues fell 2.8% y-o-y to $296.0 million due to sale of its blood screening business, whereas total Breast Health revenues improved 1.7% y-o-y to $280.5 million. Revenues from its GYN Surgical segment surged rose 11.2% y-o-y in Q2 FY17 to $101.1 million. However, Skeletal Health segment’s revenues were down by 1.6% y-o-y during the reported quarter to $21.8 million. Furthermore, the Company newly acquired Medical Aesthetics business reported total revenues of $16.0 million in Q2 FY17.

Cash Flow & Balance Sheet

During the first half of FY17, the Company generated $253.4 million of cash from operating activities versus $322.3 million in the prior-year’s comparable period. Moreover, the Company’s operating cash flow and free cash flow cash for the reported quarter came in at $83.8 million and $58.7 million, respectively.
As on April 01, 2017, the Company had $1.13 billion in cash and cash equivalents compared to a balance of $548.4 million as on September 24, 2016. Additionally, the Company reported long-term debt of $2.23 billion in its books as on April 01, 2017 down from $3.05 billion as on September 24, 2016.

Outlook

Based on its performance in Q2 FY17, the Company updated its financial guidance for full-year FY17. Hologic’s management now expects total revenues for full year FY17 to be in the range of $3.05 billion to $3.08 billion, up from previously provided guidance range of $2.79 billion to $2.83 billion. GAAP EPS for FY17 is predicted to be between $2.44 and $2.48, while non-GAAP EPS for FY17 is projected to be in the range of $1.98 to $2.02.

For Q3 FY17, the Company estimates total revenues to be between $790 million and $805 million with GAAP EPS in the range of $0.22 to $0.24. Furthermore, non-GAAP EPS for Q3 FY17 is anticipated to be in the range of $0.48 to $0.50.

Stock Performance

At the close of trading session on Thursday, May 25, 2017, Hologic’s share price finished the trading session at $43.50, rising 1.16%. A total volume of 2.30 million shares exchanged hands. The stock has soared 13.08% and 29.43% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 8.42%. The stock is trading at a PE ratio of 15.69 and currently has a market cap of $12.20 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464307

Upcoming AWS Coverage on Park Hotels & Resorts Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. announces its post-earnings coverage on Ctrip.com International, Ltd (NASDAQ: CTRP). The Company disclosed its Q1 FY17 financial results on May 10, 2017. China’s leading online travel agency outperformed top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Ctrip.com International’s competitors within the Lodging space, Park Hotels & Resorts Inc. (NYSE: PK), reported on May 03, 2017, its earnings results for Q1 ended March 31, 2017. AWS will be initiating a research report on Park Hotels & Resorts in the coming days.

Today, AWS is promoting its earnings coverage on CTRP; touching on PK. Get our free coverage by signing up to:
http://www.activewallst.com/register/.

Earnings Reviewed

For the three months ended March 31, 2017, Ctrip reported net revenues of RMB6.09 billion (US$884.05 million), representing a 46% increase from net revenues of $4.18 billion in Q1 2016. The Company’s revenue numbers topped analysts’ expectation of $866.7 million. For Q1 2017, Ctrip’s gross margin was 80% compared to 73% in Q1 2016.

Ctrip’s product development expenses for Q1 2017 fell 18% to RMB2.0 billion (US$285 million) on a y-o-y basis, primarily due to a decrease in share-based compensation charges, and accounted for 32% of the net revenues. Excluding share-based compensation charges, the Company’s non-GAAP product development expenses for the reported quarter accounted for 28% of the net revenues, down compared to 32% in the year ago same period.

For Q1 2017, Ctrip’s sales and marketing expenses increased by 22% to RMB1.9 billion (US$273 million) on a y-o-y basis, primarily due to an increase in sales and marketing related activities and accented for 31% of the net revenues. Excluding share-based compensation charges, non-GAAP sales and marketing expenses for Q1 2017 accounted for 30% of the net revenues, below the 33% in the year ago same period.

Ctrip’s income from operations for Q1 2017 was RMB414 million (US$60 million) compared to loss of RMB1.8 billion in Q1 2016. Excluding share-based compensation charges, non-GAAP income from operations was RMB936 million (US$136 million) for the reported quarter compared to RMB8 million in the prior year’s same quarter. The Company’s operating margin for the reported quarter was 7% compared to negative 44% in Q1 2016. Excluding share-based compensation charges, Ctrip reported non-GAAP operating margin of 15% compared to 0% in the prior year’s same quarter.

Net income attributable to Ctrip’s shareholders was RMB82 million (US$12 million) for Q1 2017 compared to net loss of RMB1.6 billion in Q1 2016. The Company’s diluted earnings per ADS were RMB0.15 (US$0.02) for the reported quarter. Excluding share-based compensation charges, non-GAAP diluted earnings per ADS, were RMB1.09 (US$0.16) for Q1 2017, which was also ahead of Wall Street’s expectations for a loss of $0.07 per share.

As of March 31, 2017, Ctrip’s balance of cash and cash equivalents, restricted cash, and short-term investments were RMB36 billion (US$5 billion).

Segment Results

Ctrip’s Accommodation reservation revenues for Q1 2017 were RMB2.1 billion (US$301 million), representing a 28% increase on a y-o-y basis, primarily driven by growth in accommodation reservation volume.

For Q1 2017, Ctrip’s Transportation ticketing revenues totaled RMB2.9 billion (US$418 million), representing a 48% increase compared to the year ago same quarter, primarily driven by an increase in ticketing volume and the consolidation of Skyscanner’s financial results since December 31, 2016.

Ctrip’s Packaged-tour revenues for Q1 2017 were RMB702 million (US$102 million), representing a 26% increase on a y-o-y basis, primarily driven by an increase in volume growth of organized tours and self-guided tours. The Company’s Corporate travel revenues for the reported quarter surged 25% on a y-o-y basis to RMB144 million (US$21 million), primarily driven by expansion in travel product coverage.

Business Outlook

For Q2 2017, the Company expects the net revenue growth to continue at a year-on-year rate of approximately 40%-45%. This forecast reflects Ctrip’s current and preliminary view, which is subject to change.

Stock Performance

On Thursday, May 25, 2017, the stock closed the trading session at $55.71, climbing 1.40% from its previous closing price of $54.94. A total volume of 2.61 million shares have exchanged hands. Ctrip.com’s stock price surged 12.23% in the last month, 14.77% in the past three months, and 33.05% in the previous six months. Furthermore, since the start of the year, shares of the Company have soared 39.27%. The stock currently has a market cap of $28.25 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464308

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. announces its dividend coverage for Compass Minerals International, Inc. (NYSE: CMP). Shares of Compass Minerals will begin trading ex-dividend on May 30, 2017. In order to qualify for a dividend check, investors must own the stock on or before May 29, 2017. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its ex-dividend coverage on CMP. Get our free coverage by signing up to:
http://www.activewallst.com/register/.

Dividend Declared

On May 04, 2017, Compass Minerals’ Board of Directors declared a cash dividend of $0.72 per share payable June 15, 2017, to shareholders of record as of the close of business on June 01, 2017. The new dividend rate was originally announced on February 02, 2017, where its Board of Directors approved a 3.6% increase in the Company’s quarterly cash dividend. The quarterly cash dividend was increased to $0.72 per share of common stock and will raise the annualized dividend pay-out to $2.88 per share of common stock.

At the new rate, Compass Minerals indicated the dividend represents a dividend yield of 4.73% compared to the average dividend yield for the Basic Materials sector of 2.32%. The Company has increased its dividend every year since going public in 2003.

Compass Minerals has a dividend pay-out ratio of 88.1% meaning the Company distributes $0.608 for every $1.00 earned. Analysts expect Compass Minerals to report earnings of $4.15 in the coming year, which should allow the Company to comfortably continue to cover its $2.88 annual dividend.

About the Company

Compass Minerals was founded in 1993 and is headquartered in Overland Park, Kansas. The Company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003.

Compass Minerals, produces and sells salt, and specialty plant nutrition and chemical products in the United States, Canada, Brazil, the United Kingdom, and internationally. It operates in three segments: Salt, Plant Nutrition North America, and Plant Nutrition South America.

Recent Development for Qualcomm

On May 03, 2017, Compass Minerals reported total revenue increase of 12% to $387.8 million for Q1 2017 from $345.7 million in Q1 2016, driven by the recent acquisition of Produquímica Indústria e Comércio S.A. (Produquímica), which contributed revenue of $61.3 million in the reported quarter.

For Q1 2017, Compass Minerals’ consolidated operating income totaled $41.4 million, down 44% compared to $74.3 million in the prior year’s same quarter. The decline was primarily driven by reduced salt segment earnings, offset partially by earnings from both the Company’s plant nutrition segments. Compass Minerals reported Q1 2017 net earnings of $21.5 million, or $0.63 per diluted share, compared to $49.7 million, or $1.46 per diluted share, in Q1 2016.

On April 25, 2017, Compass Minerals announced that effective immediately its Chief Financial Officer, Patrick “Doug” Linehan, is leaving the Company due to unforeseen personal circumstances. Compass Minerals stated that Linehan’s departure involves no disputes with the Company or issues regarding accounting practices, financial statements or operations. Concurrently, James “Jamie” Standen, Vice President of finance and treasurer, has been named as interim CFO and Treasurer.

Stock Performance

At the close of trading session on Thursday, May 25, 2017, Compass Minerals’ stock price slipped 1.06% to end the day at $65.25. A total volume of 324.53 thousand shares were exchanged during the session. The Company’s shares are trading at a PE ratio of 16.51 and have a dividend yield of 4.41%. The stock currently has a market cap of $2.21 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464305

Upcoming AWS Coverage on Ross Stores Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. blog coverage looks at the headline from leading global manufacturer, marketer and distributor of branded packaged specialty rice and other related food products, Amira Nature Foods Ltd (NYSE: ANFI), as the Company announced on May 24, 2017, that it has successfully expanded its distribution footprint in Germany by obtaining a national listing with Rewe Group, a major German retailer. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

One of Amira Nature Foods’ competitors within the Food – Major Diversified space, Ross Stores, Inc. (NASDAQ: ROST), reported on May 18, 2017, its financial results for Q1 2017. AWS will be initiating a research report on Ross Stores in the coming days.

Today, AWS is promoting its blog coverage on ANFI; touching on ROST. Get all of our free blog coverage and more by clicking on the link below:
http://www.activewallst.com/register/.

Benefits of the Expansion

Amira Nature Foods’ German subsidiary, AMIRA BASMATI RICE GMBH EUR currently sells its Amira, Atry, Sadry, Sativa, Scheherazade, and Sultan brands into more than 4,000 retail stores in Germany and in neighboring European countries. The national listing in Germany with Rewe will increase the Company’s total distribution in the German region to approximately 6,400 retail stores.

Karan A. Chanana, Amira Nature Foods’ Chairman and Chief Executive Officer stated:

“We are pleased to add to our geographic footprint in Germany and to further grow this geographic market for us.”

Tobias Strerath, CEO of AMIRA BASMATI RICE GMBH EUR added:

“We have worked hard over the years to service this account and we are very excited to see these efforts come to life with a national listing for our ATRY brand. This retail win is a confirmation of our hard work and dedication to the business.”

Amira Nature Foods first entered the German market through its acquisition of AMIRA BASMATI RICE GMBH EUR in December 2013. On March 08, 2017, Amira Nature Foods announced that it has acquired a portfolio of packaged specialty rice brands which include Al Amir, Al Hakim, Bano, Dalia, Hanna, and Shah Pari brands from Euro Basmati GmbH in Germany. These brands are primarily been sold through the ethnic channel in Germany.

Upcoming Earnings

On May 23, 2017, Amira Nature Foods announced that it expects to release its full year audited financial results and its Form 20-F for the fiscal year ended March 31, 2017, in July 2017. Based upon its unaudited financials, Amira Nature Foods generated revenues for the six months ended March 31, 2017, that increased by approximately 2% or more compared to the year ago same period. Additionally, the Company estimates that its adjusted EBITDA margins for the year will be broadly in-line with its historical full year adjusted EBITDA margins.

Bruce Wacha, Amira Nature Foods’ Chief Financial Officer stated:

“We are encouraged by the improved performance in the second half of our fiscal 2017. We have reached an inflection point in our business recovery and we are now positioned to report modest growth for the six months ended March 31, 2017 when compared to the same period in the prior year. We continue to focus on growth opportunities and building the business. We look forward to discussing our improved performance for fiscal 2017 and providing our outlook fiscal 2018.”

Stock Performance

On Thursday, May 25, 2017, Amira Nature Foods’ shares closed the trading session at $4.98, climbing 1.84% from its previous closing price of $4.89. A total volume of 74.56 thousand shares have exchanged hands. Shares of the company have a PE ratio of 5.41 and currently have a market cap of $184.16 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464306

Upcoming AWS Coverage on ZTO Express (Cayman) Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. blog coverage looks at the headline from Roadrunner Transportation Systems, Inc. (NYSE: RRTS) as the Company announced on May 24, 2017, that they have recruited Terence R. Rogers as the new Executive Vice President and Chief Financial Officer (CFO). He took charge of his position on the same day. Register with us now for your free membership and blog access at:
http://www.activewallst.com/register/.

One of Roadrunner Transportation Systems’ competitors within the Air Delivery & Freight Services space, ZTO Express (Cayman) Inc. (NYSE: ZTO), announced on May 17, 2017, its unaudited financial results for Q1 which ended on March 31, 2017. AWS will be initiating a research report on ZTO Express (Cayman) in the coming days.

Today, AWS is promoting its blog coverage on RRTS; touching on ZTO. Get all of our free blog coverage and more by clicking on the link below:
http://www.activewallst.com/register/.

Roadrunner Transportation is a leading transportation and logistics services provider. They are a single-source provider, offering customized LTL (Less Than Truckload), Truckload, Expedited, Third-Party Logistics (3PL), and Specialized Service solutions from 21 strategically located terminals across the US.

About the new Executive Vice President and Chief Financial Officer

Terence R. Rogers is an experienced financial professional and before joining Roadrunner Transportation, he was CFO for The Heico Companies, LLC, the parent Company for a diversified portfolio of over 35 businesses. Rogers worked at this position for four years. He also held various financial positions of increasing importance with Ryerson Inc., a leading distributor and value-added processor of industrial metals. He was with Ryerson for more than 17 years, and was the CFO when he left the Company.

Commenting on his joining, Curt Stoelting, CEO of Roadrunner Transportation said:

“I am excited to announce the addition of Terry Rogers, who is an experienced and skilled CFO, to our management team at Roadrunner. Adding Terry completes the hiring of our new executive management team. Our strong team is focused on moving the Company forward and building long-term shareholder value.”

Roger replaces Peter Armbruster, the former CFO, of Roadrunner Transportation, who was terminated due to discovery of financial discrepancies.

Shifting of its Headquarters

Roadrunner Transportation also announced that they are shifting from their corporate headquarters which was earlier at Cudahy, Wisconsin to Downers Grove, Illinois. The new headquarter will house the Company’s top management team. The decision to move was taken after taking into consideration the ease of travel for customers as well as its team members.

The office at Cudahy will continue to be operational and house key business and support functions. An estimated 185 positions will continue to be located at Cudahy. The Company does not plan to reduce its employee strength at this location.

Infusion of capital and corporate restructuring

On May 02, 2017, Roadrunner Transportation had announced the infusion of capital of $540 million from private investment firm Elliott Management. Roadrunner Transportation issued redeemable preferred stock to Elliott Management for the same. Elliott Management already has 8.6% stake in the Company. The Company used the capital infusion from Elliott Management to pay off its existing credit and boost its working capital.

The Company also announced its new management team which included Curt Stoelting as the Chief Executive Officer; Mike Gettle as the President and Chief Operating Officer; Scott Cousins as the Chief Information Officer; and Bob Milane as the General Counsel and Chief Compliance Officer.

The Company has started to put its house back in order following the termination of Peter Armbruster, the former CFO. He had been with the Company since 2005 and he was terminated from his position in March 2017 when the Company discovered accounting errors dating back to 2014 that required $20 million to $25 million in adjustments to its results. The discovery was made in January 2017.

Following the discovery, Roadrunner Transportation stock recorded a steep fall and the Company faces major legal hurdles.

Stock Performance

Roadrunner Transportation Systems’ share price finished yesterday’s trading session at $6.33, slipping 1.09%. A total volume of 127.70 thousand shares exchanged hands. The stock is trading at a PE ratio of 9.63. At Thursday’s closing price, the stock’s net capitalization stands at $242.62 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464302

Upcoming AWS Coverage on AbbVie Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. blog coverage looks at the headline from pharmaceutical giant Pfizer Inc. (NYSE: PFE) as the Company announced on May 24, 2017, that it had received an unsolicited mini-tender offer from Ontario, Canada based investment firm TRC Capital Corporation. Pfizer has recommended that its shareholders do not respond to TRC’s offer as it is below the market price of Pfizer’s shares. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

One of Pfizer’s competitors within the Drug Manufacturers – Major space, AbbVie Inc. (NYSE: ABBV), announced on April 27, 2017, its financial results for Q1 2017 which ended on March 31, 2017. AWS will be initiating a research report on AbbVie in the coming days.

Today, AWS is promoting its blog coverage on PFE; touching on ABBV. Get all of our free blog coverage and more by clicking on the link below:
http://www.activewallst.com/register/.

TRC’s Mini-Tender Offer

TRC offered to buy up to 4 million Pfizer’s shares at a price of $31.60 per share in cash. The offer represents approximately 0.067% of Pfizer’s total outstanding shares as on May 15, 2017, the date when the offer was made.

According to Pfizer, TRC’s offer price of $31.60 per share is approximately 4.27 % lower than the closing share price of $33.01 for Pfizer’s stock on May 12, 2017, the last trading day before the offer was made.

Reasons for Pfizer’s negative recommendation

The primary reason that Pfizer wants shareholders to reject TRC’s offer is that it is below market price.

The other major reason is TRC’s modus operandi. TRC has a history of making mini-tender offers to various Companies to acquire their shares at less than market value. A mini-tender offer is usually made to acquire less than 5% common stock of any Company. The offer is made in such a manner that the investors are caught unaware and do not get the time to compare the offer price and actual market price of their shares. The US Securities and Exchange Commission (SEC) mandates that any offer for more than 5% of any Company’s outstanding shares have to adhere to many disclosure and procedural requirements. By making a mini tender offer this SEC requirement can be circumvented. This leaves shareholder’s unprotected and vulnerable as they are not protected by the US securities laws.

The matter is so serious that the SEC has already cautioned investors about the dangers associated with mini-tenders. The SEC has provided with a list of ‘Dos and Don’ts’ as guidance to investors on its site.

In the meanwhile, Pfizer has urged its investors to get the latest market prices of their shares by either consulting with their brokers, financial advisors, and be cautious about TRC’s offer. Those investors who have already responded to TRC’s can withdraw their shares before the expiration of the offer date, i.e. June 14, 2017.

Some of the recent mini-tender offer from TRC

On May 05, 2017 TELUS Corporation (NYSE: TU) received an unsolicited mini-tender offer from TRC, which the Company asked its shareholders to reject as the offer was below its market price.

On April 07, 2017, Enbridge Inc. (NYSE: ENB) cautioned its shareholders that the mini-tender offer made by TRC is market price of Enbridge’s shares.

On April 19, 2017, The Kroger Co. (NYSE: KR) received an unsolicited “mini-tender” offer from TRC Capital Corporation, which was below the market price for Kroger’s shares. It recommended its shareholders to reject the offer.

On March 10, 2017, BCE Inc. (NYSE: BCE) recommended that its shareholders reject TRC Capital’s “mini-tender offer” as the offer is below market price for BCE’s shares.

On March 24, 2017, Exxon Mobil Corporation (NYSE: XOM) recommended that its stockholders do not tender their shares in response to TRC Capital’s offer because the offer is at a price below the current market price for ExxonMobil’s shares.

Stock Performance

At the close of trading session on Thursday, May 25, 2017, Pfizer’s stock price rose slightly by 0.34% to end the day at $32.16. A total volume of 17.29 million shares were exchanged during the session. The Company’s share price has gained 2.65% in the past six months. The Company’s shares are trading at a PE ratio of 26.96 and have a dividend yield of 3.98%. The stock currently has a market cap of $193.15 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464303

Upcoming AWS Coverage on Camden Property Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. blog coverage looks at the headline from New York based Two Harbors Investment Corp. (NYSE: TWO) as the Company announced on May 24, 2017, that it intends to transfer its Commercial Real Estate Assets to Granite Point Mortgage Trust Inc. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

One of Two Harbors Investment’s competitors within the REIT – Residential space, Camden Property Trust (NYSE: CPT), announced on May 04, 2017, its operating results for Q1 2017 which ended on March 31, 2017. AWS will be initiating a research report on Camden Property in the coming days.

Today, AWS is promoting its blog coverage on TWO; touching on CPT. Get all of our free blog coverage and more by clicking on the link below:
http://www.activewallst.com/register/

Two Harbors Investment is a leading hybrid mortgage real estate investment trust (REIT), and a Maryland Corporation. It focuses on investing, financing, and managing residential mortgage-backed securities (RMBS) and related investments. Two Harbors Investment is externally managed and advised by PRCM Advisers LLC, a wholly owned subsidiary of Pine River Capital Management L.P.

The Plan

Two Harbors Investment had started Granite Point, a Maryland corporation, with the intention of expanding the commercial real estate lending business.

With the formation of Granite Point, Two Harbors Investment expected it to concentrate on directly originating, investing in, and managing a portfolio of commercial real estate loans and other debt and debt-like instruments. These loans, debt and debt-like instruments would be secured by institutional quality commercial properties which would be managed by experienced owners at lucrative markets across the US. The Pine River Capital Management L.P., which is the parent Company of Two Harbors Investment’s external manager, will also externally manage Granit e Point.

The transfer of assets will need to be approved by the special committee and 2 members of Two Harbors Investment’s Board of Directors. The finalization of the requisite documentation with regards to the transfer will be done on the terms that are acceptable to Two Harbors Investment and the special committee. This will also be done in accordance to the closing conditions of the transaction including clearance from SEC and other market factors.

Reasons for the transfer of assets and its result

Granite Point has recently filed for an IPO of over $100 million. The Company plans to list its shares at the New York Stock Exchange (NYSE) under the ticker “GMPT”. Once the IPO closes, the commercial real estate assets will be immediately transferred to Granite Point. Two Harbors Investment expects to receive shares in Granite Point in exchange for the commercial real estate assets transferred. The amount of capital raised via the IPO as well as the value of the commercial real estate assets transferred to Granite Point will determine the number of shares to be allocated to Two Harbors Investment. This is again subject to the approval of Board of Directors and applicable SEC (US Securities Exchange Commission) laws.

Once the shares of Granite Point are allocated to Two Harbors Investment after the IPO, Two Harbors Investment plans to distribute its portion of shares to its shareholders via a special dividend. This will be possible once the lock-up period on the Granite Point shares expires after the completion of the IPO.

Way forward

A committee has been formed by Two Harbors Investment’s Board of Directors, which consists of independent directors. This committee has been tasked with the review, negotiation, and approval of the proposed transaction. The committee has also retained the services of Freshfields Bruckhaus Deringer LLP as its legal counsel and Credit Suisse as its financial adviser to assist in the transfer of assets and represent the interests of Two Harbors Investment and its shareholders in the matter.

Stock Performance

On Thursday, May 25, 2017, the stock closed the trading session at $10.09, slightly slipping 0.10% from its previous closing price of $10.10. A total volume of 2.24 million shares have exchanged hands. Two Harbors Investment’s stock price surged 18.71% in the past six months and 18.71% in the previous twelve months. Furthermore, on a year to date basis, the stock rallied 15.71%. The stock is trading at a PE ratio of 6.82 and has a dividend yield of 9.91%. The stock currently has a market cap of $3.53 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 464299